News

Thought Leaders from McKesson Specialty Health and The US Oncology Network Are Key Presenters at the 2017 Community Oncology Conference

April 27, 2017

Presentations will focus on innovative solutions for community oncology success and cancer care delivery in today’s challenging environment

Read More

US Oncology Research Enrolls 2,900 Patients in Leading-Edge Clinical Trials in Twelve Months

April 25, 2017

Program reaches recruitment milestone while bringing novel treatments to community cancer centers

The Woodlands, Texas (April 25, 2017)US Oncology Research, one of the largest community-based oncology research programs in the United States, enrolled more than 2,900 subjects into clinical trials during the fiscal year ended March 31, 2017. The participation of these patients in leading-edge oncology trials for a wide range of cancer types contributed to eight cancer therapies receiving FDA approvals, making promising new treatments available to cancer patients across the nation. Contributing to so many FDA approvals in one fiscal year is unprecedented for US Oncology Research and demonstrates the organization’s strong ongoing commitment to play a vital role in understanding cancer and identifying effective therapies. In total, US Oncology Research has enrolled more than 66,000 patients into clinical trials since its inception in 1992.

Read More

Medical Oncology Hematology Consultants Joins The US Oncology Network

March 1, 2017

Practice with largest infusion treatment center in Delaware gains access to world-class treatments and enhances its cutting-edge research program

Read More

Black Book Research Recognizes iKnowMed as the Number One Ranked Oncology Electronic Health Record for Sixth Consecutive Year

February 28, 2017

Number One Rankings in Key Performance Areas Reinforces McKesson Specialty Health’s Leading Position in the Oncology and Hematology Market

The Woodlands, Texas (Feb. 28, 2017) — For the sixth year in a row, iKnowMedSM electronic health record (EHR) has been named the top-ranked EHR platform for oncologists and hematologists by Black BookTM Research, an unbiased industry-leading source for polling, surveys and market research. iKnowMed was recognized for its superior focus on meeting the unique needs of community-based oncology practices.

Read More

McKesson Specialty Health and The US Oncology Network to Showcase Value-Based Care Expertise During Cancer Center Business Summit

February 2, 2017

The Woodlands, Texas (February 2, 2017) — Representatives from McKesson Specialty Health and The US Oncology Network (The Network) will be presenting at the 10th Cancer Center Business Summit, which will be held Monday and Tuesday, February 6-7 at The Aria Resort in Las Vegas, Nevada. The Summit aims to showcase innovative organizations and how they are responding to changes occurring in the cancer care marketplace.

Read More

Southern Cancer Center Joins The US Oncology Network

February 1, 2017

Affiliation with the largest network of its kind strengthens Southern Cancer Center’s ability to remain independent, providing access to vast resources to enhance care

Read More

Vantage Oncology’s 50 centers and more than 350 affiliated physicians join The US Oncology Network

January 26, 2017

The Woodlands, Texas (January 26, 2017) - The US Oncology Network (“The Network”) announced today, as part of McKesson Specialty Health’s ongoing integration with Vantage Oncology, that 50 centers in 13 states and more than 350 affiliated physicians have joined The Network.

The US Oncology Network provides effective and comprehensive practice management capabilities and value-based care expertise critical for navigating today’s challenging healthcare landscape. The Network is supported by McKesson Specialty Health, an industry leader that works together with stakeholders across the healthcare delivery system to preserve and strengthen specialty care.

Read More

McKesson Specialty Health and The US Oncology Network invited to participate in the final White House “Making Health Care Better” Series focused on Community Oncology

January 11, 2017

Dr. Debra Patt shared expertise on the event’s Support Services and Survivorship Panel

The Woodlands, Texas (January 11, 2017) — Representatives from McKesson Specialty Health and The US Oncology Network (The Network) were invited to participate in a community oncology event as part of the White House “Making Health Care Better” Series, which highlights progress made in improving the health system over the past eight years. The President’s Health Policy Team collaborated with the Cancer Moonshot program to host the event and put a spotlight on the role and importance of community oncology in cancer care. The event was held on Wednesday, January 11 from 8am to 12pm ET at the White House and was only open to invited attendees.

Read More

McKesson Specialty Health Expands Operations with New Office in Downtown Evansville, Indiana

December 13, 2016

When Fully Staffed, the McKesson Specialty Health Indiana Regional Billing Office will Employ More than 100

EVANSVILLE, Indiana (December 13, 2016) — Evansville Mayor Lloyd Winnecke and McKesson Specialty Health announced that McKesson will expand its Revenue Cycle Services operations with the opening of a new office in Evansville, Indiana in early 2017. When fully staffed, the new McKesson Specialty Health Indiana Regional Billing Office will employ more than 100.

“I am excited that McKesson Specialty Health has chosen Evansville to locate this new office and create additional jobs for the City and the region,” said Mayor Winnecke. “This reinforces our focus and efforts of fostering job creation and business growth, and I expect McKesson’s industry leadership will serve as an invaluable contribution to the Indiana economy.”

Read More

US Oncology Research Annual Science Forum focuses on delivering the latest research opportunities to patients in the community setting

December 8, 2016

15th Annual Science Forum promotes clinical research education, innovation and collaboration

The Woodlands, Texas (December 8, 2016)US Oncology Research held its 15th Annual Science Forum earlier this fall. The annual meeting for all US Oncology Research affiliated investigators was held in Dallas and highlighted the importance of clinical trials as a treatment option for cancer patients.

“A clinical trial saved my life,” said Rhonda Jenkins, breast cancer survivor, clinical trial participant and patient of Texas Oncology, an affiliate of US Oncology Research.

Read More

Blood & Cancer Center Joins Florida Cancer Affiliates

December 1, 2016

Collaboration strengthens both practices, enhancing patient care, research opportunities and access to services throughout Northern Florida

Ocala, Fla. (December 1, 2016) — Florida Cancer Affiliates (FCA), a premier provider of advanced cancer care services in Florida, announced that Blood & Cancer Center has joined its practice. Anju Vasudevan, M.D., and Cecil Robertson, M.D., oncologists and hematologists with Blood & Cancer Center, will unite with Florida Cancer Affiliate’s group of physicians to provide comprehensive state-of-the-art cancer care in convenient, patient-friendly community settings. FCA is an affiliate of The US Oncology Network (The Network), one of the nation’s largest networks of integrated community-based oncology practices.

Read More

US Oncology Research Announces Schedule of Presentations at the 2016 American Society of Hematology Annual Meeting and Exposition

November 30, 2016

Sixteen presentations on clinical research conducted by top US Oncology Research affiliated investigators will take place at ASH 2016

The Woodlands, Texas (November 30, 2016) — More than 20 leading investigators affiliated with US Oncology Research participated in sixteen studies that will be presented at the 58th American Society of Hematology Annual Meeting and Exposition (ASH), a premier scientific event in malignant and non-malignant hematology, held December 3-6 in San Diego. Six oral and ten poster presentations co-authored by US Oncology Research affiliated investigators cover topics such as diffuse large B-cell lymphoma (DLBCL), multiple myeloma, small lymphocytic leukemia, and mantle cell lymphoma.

Read More

Rocky Mountain Cancer Centers First In Region to Offer Newly Approved Gallium DOTATATE PET/CT for Neuroendocrine Tumors

November 15, 2016

Denver, Colo. (November 15, 2016) – Rocky Mountain Cancer Centers (RMCC), a practice in The US Oncology Network, is the first in the Rocky Mountain region, and one of only a handful of sites in the United States, to offer the newly approved Ga-68 DOTATATE PET/CT for patients with neuroendocrine tumors (NETs). The U.S. Food and Drug Administration (FDA) recently approved the test. Marketed under the name Netspot™, gallium 68 DOTATATE is a radioactive diagnostic agent used in positron emission tomography (PET) imaging. Because the gallium DOTATATE binds strongly to the receptors of neuroendocrine tumor cells, it effectively detects tumors and metastases, not seen on other standard scans, and reveals the locations of tumors.

Read More

Lancet Oncology Multi-Part Study on Oncology Drug Safety in the 21st Century Reveals the Need for New Approaches to Biosimilar and Generic Oncology Drugs

November 2, 2016

Much reform is needed before these new oncology drugs are safe, effective, affordable choices for U.S. patients

Read More

OHC Joins The US Oncology Network, Gaining Resources to Advance Quality Care and Operational Efficiency

November 1, 2016

Practice gains access to world-class treatments and enhances its cutting-edge research program

Cincinnati, Ohio (November 1, 2016) – OHC (Oncology Hematology Care), the premier provider of advanced treatments for cancer and blood disorders in the Greater Cincinnati area for more than 30 years, has joined The US Oncology Network, one of the nation’s largest associations of community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. By joining The Network, OHC enhances its ability to provide patients high-quality care as well as access to some of the most advanced cancer treatments available today, all delivered in convenient neighborhood locations close to the patient’s home. The practice also gains a wealth of resources, expertise, innovative technologies and business support services from The Network to help them succeed in transitioning to value-based healthcare.

Read More

Varian and McKesson Specialty Health Announce Strategic Agreement for Advanced Radiotherapy Equipment and Software

October 26, 2016

PALO ALTO, Calif. and The Woodlands, Texas (October 26, 2016) — Varian Medical Systems (NYSE: VAR) and McKesson Specialty Health today announced a strategic agreement for the deployment and servicing of Varian advanced radiotherapy equipment and software over a three-year period across The US Oncology Network and Vantage Oncology affiliated sites of care. This multiyear agreement delivers significant value to oncology providers in The US Oncology Network, which now operates the largest system of radiotherapy facilities in the U.S. following the acquisition of Vantage Oncology earlier this year.

Read More

Compass Oncology breaks ground on multi-disciplinary cancer center

October 18, 2016

More than 80 healthcare employees will provide Westside residents with comprehensive care at new state-of-the-art facility

Tigard, Oregon (October 18, 2016) — The largest independent cancer practice in the Northwest has broken ground for a new multi-disciplinary center in Tigard, set to open May 2018. Construction at the site will begin spring 2017.

Compass Oncology, a practice in The US Oncology Network, one of the nation’s largest community-based cancer treatment and research networks, will build a 36,000 square-foot center near SW 72nd and SW Dartmouth in what is known as the Tigard Triangle.

Read More

The US Oncology Network Selects Myriad Genetics as Preferred Provider for Hereditary Cancer Testing

October 4, 2016

THE WOODLANDS, Texas and SALT LAKE CITY, Utah, October 4, 2016 – Myriad Genetics, Inc. (NASDAQ: MYGN) and The US Oncology Network (The Network) announced today that The Network has selected Myriad Genetic Laboratories as its preferred provider laboratory for hereditary cancer testing. The US Oncology Network is one of the nation’s largest networks of integrated, community-based, and independent physician practices dedicated to advancing high-quality, evidence-based cancer care. With more than 1,000 affiliated physicians in 19 states, providers in The Network treat over 800,000 patients every year.

Read More

Arizona Oncology implements advanced cervical imaging technology to assist with the early detection of cervical cancer

September 22, 2016

September 28th is National Women’s Health and Fitness Day and women are encouraged to take control of their health

Scottsdale, Ariz. (September 22, 2016) – Arizona Oncology, one of the largest medical groups in Arizona devoted to cancer care and a practice in The US Oncology Network, is the first in Arizona to utilize the latest technology and advancement in the early detection of cervical cancer and pre-cancers. The practice has implemented the DYSIS® Advanced Cervical Imaging System. This advanced digital colposcope, an instrument for examining the cervix, has computer-aided mapping technology and can enhance a doctor’s ability to diagnose and manage cervical neoplasia, precancerous cells, by detecting changes in a woman’s cervix after an abnormal Pap smear.

Read More

Arizona Oncology Adds Four Gynecologic Oncologists, Expanding World-Class Gynecologic Cancer Services throughout the Region

September 12, 2016

New physicians enhance access to specialized gynecologic care across the Valley

Read More

Pages